NCT00128778 2023-03-06Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer PatientsSpanish Breast Cancer Research GroupPhase 4 Completed288 enrolled
NCT00727961 2017-06-08A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)Merck Sharp & Dohme LLCPhase 4 Completed58 enrolled 10 charts